Matthew R. Gardner

2.1k total citations
38 papers, 785 citations indexed

About

Matthew R. Gardner is a scholar working on Virology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Matthew R. Gardner has authored 38 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Virology, 11 papers in Molecular Biology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Matthew R. Gardner's work include HIV Research and Treatment (22 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Virus-based gene therapy research (9 papers). Matthew R. Gardner is often cited by papers focused on HIV Research and Treatment (22 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Virus-based gene therapy research (9 papers). Matthew R. Gardner collaborates with scholars based in United States, United Kingdom and China. Matthew R. Gardner's co-authors include Michael Farzan, Kelli Hoover, David Hughes, James M. Slavicek, James McNeil, Michael Grove, Barnett Alfant, Meredith E. Davis-Gardner, Brian D. Quinlan and Stephen Dorling and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Matthew R. Gardner

38 papers receiving 767 citations

Peers

Countries citing papers authored by Matthew R. Gardner

Since Specialization

Citations

This map shows the geographic impact of Matthew R. Gardner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew R. Gardner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew R. Gardner more than expected).

Fields of papers citing papers by Matthew R. Gardner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew R. Gardner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew R. Gardner. The network helps show where Matthew R. Gardner may publish in the future.

Co-authorship network of co-authors of Matthew R. Gardner

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew R. Gardner. A scholar is included among the top collaborators of Matthew R. Gardner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew R. Gardner. Matthew R. Gardner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adeno-associated viral delivery of Env-specific antibodies prevents SIV rebound after discontinuing antiretroviral therapy 2025 ·Science Immunology ·Vadim A. Klenchin, (unknown), (unknown), Saverio Capuano, Rosemarie D. Mason, Guangping Gao, Aimee Teo Broman, (unknown), Taina T. Immonen, Christine M. Fennessey, Brandon F. Keele, Jeffrey D. Lifson, Mario Roederer, Matthew R. Gardner, David T. Evans	2
2	Determinants of successful AAV-vectored delivery of HIV-1 bNAbs in early life 2025 ·Nature ·Amir Ardeshir, (unknown), (unknown), (unknown), (unknown), Lourdes Adamson, Marcelo J. Kuroda, (unknown), (unknown), Sebastian Fuchs, José M. Martinez-Navío, Matthew R. Gardner, Koen K. A. Van Rompay, Diogo M. Magnani, Jeffrey D. Lifson, Guangping Gao, Michael Farzan, Ronald C. Desrosiers, Jishnu Das, Maurício A. Martins	1
3	Single particle charge detection mass spectrometry enables molecular characterization of lipid nanoparticles and mRNA packaging 2025 ·Journal of Controlled Release ·Zachary M. Miller, (unknown), Yuexuan Li, Matthew R. Gardner, Justin W. Torpey, Evan R. Williams	1
4	A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors 2023 ·Frontiers in Immunology ·Meredith E. Davis-Gardner, (unknown), (unknown), Katja Pekrun, (unknown), Kim L. Weisgrau, Jessica Furlott, Eva G. Rakasz, Mark A. Kay, Guangping Gao, Michael Farzan, Matthew R. Gardner	10
5	A lentiviral vector B cell gene therapy platform for the delivery of the anti-HIV-1 eCD4-Ig-knob-in-hole-reversed immunoadhesin 2023 ·Molecular Therapy — Methods & Clinical Development ·(unknown), (unknown), Daniel P. Leaman, Rene Yu-Hong Cheng, (unknown), (unknown), (unknown), Iram Khan, (unknown), Matthew R. Gardner, Michael Farzan, David J. Rawlings, Michael B. Zwick, Richard G. James, Bruce E. Torbett	7
6	Seroprevalence of Adeno-Associated Virus Neutralizing Antibodies in Males with Duchenne Muscular Dystrophy 2022 ·Human Gene Therapy ·(unknown), (unknown), (unknown), (unknown), H. Phan, (unknown), (unknown), (unknown), (unknown), David Lee, Thomas H. Vanderford, Matthew R. Gardner	14
7	High concordance of ELISA and neutralization assays allows for the detection of antibodies to individual AAV serotypes 2022 ·Molecular Therapy — Methods & Clinical Development ·Matthew R. Gardner, (unknown), (unknown), José M. Martinez-Navío, Sebastian Fuchs, Guangping Gao, Ronald C. Desrosiers	20
8	Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2 2021 ·PLoS Pathogens ·Huihui Mou, Brian D. Quinlan, Haiyong Peng, Guanqun Liu, Yan Guo, Shoujiao Peng, Lizhou Zhang, Meredith E. Davis-Gardner, Matthew R. Gardner, Gogce Crynen, (unknown), Zhi Xiang Voo, Charles C. Bailey, Michael D. Alpert, Christoph Rader, Michaela U. Gack, Hyeryun Choe, Michael Farzan	34
9	Promise and Progress of an HIV-1 Cure by Adeno-Associated Virus Vector Delivery of Anti-HIV-1 Biologics 2020 ·Frontiers in Cellular and Infection Microbiology ·Matthew R. Gardner	26
10	Anti-drug Antibody Responses Impair Prophylaxis Mediated by AAV-Delivered HIV-1 Broadly Neutralizing Antibodies 2019 ·Molecular Therapy ·Matthew R. Gardner, (unknown), Lisa Kattenhorn, Meredith E. Davis-Gardner, Amber S. Zhou, Barnett Alfant, (unknown), (unknown), José M. Martinez-Navío, Sebastian Fuchs, Ronald C. Desrosiers, Guangping Gao, Jeffrey D. Lifson, Michael Farzan	44
11	AAV-delivered eCD4-Ig protects rhesus macaques from high-dose SIVmac239 challenges 2019 ·Science Translational Medicine ·Matthew R. Gardner, Christoph H. Fellinger, Lisa Kattenhorn, Meredith E. Davis-Gardner, (unknown), Barnett Alfant, Amber S. Zhou, (unknown), (unknown), (unknown), Kimberly L. Weisgrau, Eva G. Rakasz, Jeffrey D. Lifson, Guangping Gao, Nancy Schultz‐Darken, Michael Farzan	35
12	Diverse pathways of escape from all well-characterized VRC01-class broadly neutralizing HIV-1 antibodies 2018 ·PLoS Pathogens ·Yuka Otsuka, Kimberly Schmitt, Brian D. Quinlan, Matthew R. Gardner, Barnett Alfant, Adrian Reich, Michael Farzan, Hyeryun Choe	11
13	HIV-1 inhibitory properties of eCD4-Igmim2 determined using an Env-mediated membrane fusion assay 2018 ·PLoS ONE ·Edward Yang, Matthew R. Gardner, Amber S. Zhou, Michael Farzan, Ann M. Arvin, Stefan L. Oliver	1
14	Conditional Regulation of Gene Expression by Ligand-Induced Occlusion of a MicroRNA Target Sequence 2018 ·Molecular Therapy ·Huihui Mou, Guocai Zhong, Matthew R. Gardner, Haimin Wang, Yiwen Wang, (unknown), Michael Farzan	23
15	Engineering antibody-like inhibitors to prevent and treat HIV-1 infection 2017 ·Current Opinion in HIV and AIDS ·Matthew R. Gardner, Michael Farzan	17
16	eCD4-Ig promotes ADCC activity of sera from HIV-1-infected patients 2017 ·PLoS Pathogens ·Meredith E. Davis-Gardner, Matthew R. Gardner, Barnett Alfant, Michael Farzan	21
17	An ensemble solar power output forecasting model through statistical learning of historical weather dataset 2016 ·Jiahui Guo, Shutang You, Can Huang, Hesen Liu, Dao Zhou, (unknown), (unknown), Yilu Liu, Jim Glass, Matthew R. Gardner, (unknown)	14
18	Mechanism for Selective Synaptic Wiring of Rod Photoreceptors into the Retinal Circuitry and Its Role in Vision 2015 ·Neuron ·Yan Cao, Ignacio Sarria, (unknown), Naomi Kamasawa, Cesare Orlandi, Kiely N. James, Jennifer L. Hazen, Matthew R. Gardner, Michael Farzan, Amy Lee, Sheila A. Baker, Kristin K. Baldwin, Alapakkam P. Sampath, Kirill A. Martemyanov	93
19	Direct Expression and Validation of Phage-selected Peptide Variants in Mammalian Cells 2013 ·Journal of Biological Chemistry ·Brian D. Quinlan, Matthew R. Gardner, (unknown), Jessica J. Chiang, Michael Farzan	8
20	Pathogenesis of Lymantria dispar multiple nucleopolyhedrovirus in L. dispar and mechanisms of developmental resistance 2010 ·Journal of General Virology ·Jeremy N. McNeil, Diana Cox-Foster, Matthew R. Gardner, J Slavíček, Suzanne M. Thiem, Kelli Hoover	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact